Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-08-11

FDA Approved: RILUZOLE — Supplemental Application (IMPAX LABS)

View source ↗

Summary

FDA supplemental application for riluzole by Impax Labs; indicates a supplemental approval process for riluzole's authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

SUPPL AP for RILUZOLE (RILUZOLE)